Table 2.
Class of Mutation | Class I | Class II | Class III | Class IV | Class V | Class VI |
---|---|---|---|---|---|---|
Severity | Severe | Severe | Severe | Mild | Mild | Mild |
Type | Nonsense/ Frame-shift |
Missense; amino acid deletion | Missense | Missense | Missense splicing defect | Missense |
Frequent mutation | G542X, R553X, R1162X, W1282X | G85E, I507del, F508del, N1303K | S549R, G551D, G1349D | R117H, R347P, R334W, R1070W | A455E 3272-26A > G |
4326del TC, Gln1412X, 4279insA |
CFTR defect | No CFTR synthesis | CFTR trafficking and processing defect | Abnormal channel function, block in regulation; defecting gaiting regulation | Abnormal channel function, decreased conductance | Reduced synthesis of CFTR protein | Decreased protein stability |
Potential therapy | Read-throug agents (Ataluren, amynoglicosydes) | Correctors (+Potentiators) Lumacaftor (+Ivacaftor) | Potentiators (Ivacaftor) | Potentiators (Ivacaftor) | Splicing modulators amplifiers | Stabilizers HGF (hepatocyte growth factor) |